Financial News
Articles published by Marinus Pharmaceuticals
![](https://mms.businesswire.com/media/20230727626834/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230713697795/en/1638593/5/marinus-color.jpg)
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
July 13, 2023
Via Business Wire
Tickers
MRNS
![](https://mms.businesswire.com/media/20230621023451/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230602005299/en/1638593/5/marinus-color.jpg)
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
June 02, 2023
Via Business Wire
Tickers
MRNS
![](https://mms.businesswire.com/media/20230525005802/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230517005563/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230511005063/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230509005832/en/1638593/5/marinus-color.jpg)
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
May 09, 2023
Via Business Wire
Tickers
MRNS
![](https://mms.businesswire.com/media/20230503005050/en/1638593/5/marinus-color.jpg)
Via Business Wire
Tickers
MRNS
![](https://mms.businesswire.com/media/20230427005079/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230418005114/en/1638593/5/marinus-color.jpg)
Via Business Wire
Tickers
MRNS
![](https://mms.businesswire.com/media/20230406005640/en/1638593/5/marinus-color.jpg)
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 06, 2023
Via Business Wire
Tickers
MRNS
![](https://mms.businesswire.com/media/20230322005508/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230307005068/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230306005761/en/1638593/5/marinus-color.jpg)
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
March 06, 2023
Via Business Wire
Tickers
MRNS
![](https://mms.businesswire.com/media/20230207005156/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20230210005013/en/1638593/5/marinus-color.jpg)
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 10, 2023
Via Business Wire
Tickers
MRNS
![](https://mms.businesswire.com/media/20230207005159/en/1638593/5/marinus-color.jpg)
Marinus Pharmaceuticals to Present at Upcoming Investor Conferences
February 07, 2023
Via Business Wire
Tickers
MRNS
![](https://mms.businesswire.com/media/20230130005041/en/1638593/5/marinus-color.jpg)
Via Business Wire
Tickers
MRNS
![](https://mms.businesswire.com/media/20230109005693/en/1638593/5/marinus-color.jpg)
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 09, 2023
Via Business Wire
Tickers
MRNS
![](https://mms.businesswire.com/media/20230105005955/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20221209005423/en/1638593/5/marinus-color.jpg)
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
December 09, 2022
Via Business Wire
Tickers
MRNS
![](https://mms.businesswire.com/media/20221130006053/en/1638593/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20221118005002/en/1638593/5/marinus-color.jpg)
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
November 18, 2022
Via Business Wire
Tickers
MRNS
![](https://mms.businesswire.com/media/20221116005154/en/1638542/5/marinus-color.jpg)
![](https://mms.businesswire.com/media/20221107006219/en/1628887/5/marinus-color.jpg)
Marinus Pharmaceuticals Announces Pricing of $60 Million Public Offering
November 07, 2022
Via Business Wire
Tickers
MRNS
![](https://mms.businesswire.com/media/20221107006134/en/1628497/5/marinus-color.jpg)
Marinus Pharmaceuticals Announces Proposed Public Offering
November 07, 2022
Via Business Wire
Tickers
MRNS
![](https://mms.businesswire.com/media/20221107005871/en/1627836/5/marinus-color.jpg)
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results
November 07, 2022
Via Business Wire
Tickers
MRNS
![](https://mms.businesswire.com/media/20221031005137/en/1618147/5/marinus-color.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.